Researcher

Carl June

Profile

Institution

University of Pennsylvania

Field

Immunology

Carl June is a pioneer of CAR-T cell therapy who developed the first FDA-approved gene therapy, Kymriah, for cancer treatment. His work in engineering patients' own immune cells to attack tumors has transformed cancer immunotherapy.

Industry Ties

Industry Ties

NovartisTmunity TherapeuticsCapstan Therapeutics

Verified employment, education, publications and profile data sourced from ORCID. Locked — unlock to view.

Fields

• Immunology